The first step for losing weight in New York City is to know whether you are overweight or obese, and calculate how many pounds do you need to lose weight to be in the normal range.
The most effective and practical way to know your weight relative to your height is the age old BMI scale or body mass index scale. Although not perfect, the BMI works for most normal body built people and gives an idea of where you stand.
Weight loss step 2.
Understand that it is not all BMI – it is also the distribution of body weight. For example, two people with the same BMI, one has very good distribution of weight, and the other has a lot of belly fat – the one with excess belly fat is at higher health risk. To know this, a very simple and practical way is to measure waist circumference.
A waist circumference of 40 inches or above for men and 35 inches and above for women is considered to increase the risks associated with belly fat. These numbers are 5 lower for Asians – Asian men have a cut of 35 inches and Asian women have a cut off of 30 inches in terms of the waist circumference.
Another method used is waist to hip ratio – the ideal being below 1 for men and below 0.8 for women.
Weight loss step 3.
Let us say, you know your BMI is a bit high or you do have some belly fat, you may want to consider losing weight.
Before starting a weight loss program, you may want to know your weight loss options.
Once you understand the above, you may want to choose a weight loss program in NYC that is right for you.
If you have health insurance and want to lose weight under careful guidance of a well trained and experienced weight loss doctor in NYC, you may want to consider the unique W8MD’s insurance physician weight loss program in Brooklyn, NY.
Call 718-946-5500 to learn more. Limited acceptance at this time in the insurance weight loss program NYC due to popular demand.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
BMI, which measures body fat based on an individual’s weight and height, is used to define the obesity and overweight categories. According to the Centers for Disease Control and Prevention, more than one-third of adults in the United States are obese.
“Obesity threatens the overall well being of patients and is a major public health concern,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. “The approval of this drug, used responsibly in combination with a healthy diet and lifestyle, provides a treatment option for Americans who are obese or are overweight and have at least one weight-related comorbid condition.”
Belviq works by activating the serotonin 2C receptor in the brain. Activation of this receptor may help a person eat less and feel full after eating smaller amounts of food.
The safety and efficacy of Belviq were evaluated in three randomized, placebo-controlled trials that included nearly 8,000 obese and overweight patients, with and without type 2 diabetes, treated for 52 to 104 weeks. All participants received lifestyle modification that consisted of a reduced calorie diet and exercise counseling. Compared with placebo, treatment with Belviq for up to one year was associated with average weight loss ranging from 3 percent to 3.7 percent.
About 47 percent of patients without type 2 diabetes lost at least 5 percent of their body weight compared with about 23 percent of patients treated with placebo. In people with type 2 diabetes, about 38 percent of patients treated with Belviq and 16 percent treated with placebo lost at least 5 percent of their body weight. Belviq treatment was associated with favorable changes in glycemic control in those with type 2 diabetes. The approved labeling for Belviq recommends that the drug be discontinued in patients who fail to lose 5 percent of their body weight after 12 weeks of treatment, as these patients are unlikely to achieve clinically meaningful weight loss with continued treatment.
Belviq should not be used during pregnancy. Treatment with Belviq may cause serious side effects, including serotonin syndrome, particularly when taken with certain medicines that increase serotonin levels or activate serotonin receptors. These include, but are not limited to, drugs commonly used to treat depression and migraine. Belviq may also cause disturbances in attention or memory.
Available with prescription at many US Pharmacies Starting From Mid June 2013.
Where can I find a doctor to discuss if Belviq is right for me?
W8MD Medical Weight Loss Centers of America’s physicians are among the first obesity medicine physicians to offer Belviq for obese or qualified overweight patients after a physical examination by the weight loss physician.
Belviq costs approximately $3000/year per patient or about $250-275/month. Your insurance might cover this medication. Aetna and Blue Cross have announced coverage for Belviq. Check with your insurance carrier to see if they will cover this medication.
How can W8MD Medical Weight Loss Center’s Insurance Physician Weight Loss Program in Greater Philadelphia, New Jersey and New York City Help?
Did you know that 1 in 3 people have insulin resistance or are considered “pre” diabetic which could be the main reason that people are overweight? Losing just 5-10% of your weight will help you reduce risks of heart attacks, diabetes and even some cancers.
Our physicians and staff are committed to offering a comprehensive and individualized approach. W8MD physicians partner with each patient to develop a custom weight management program to best meet their individual needs. If you are a bit overweight or obese, take long term medications for cholesterol, blood pressure or diabetes but your doctor has nothing to offer for weight loss other than simply say “lose weight”, you may want to consider W8MD!
Under the direction of Dr. Prab Tumpati, W8MD Weight Loss Centers can help you overcome obesity and to make
a difference. Dr. Tumpati has passed a written board examination in the field of Bariatric Medicine and is also Board Certified in Sleep Medicine and Internal Medicine. The doctor’s of W8MD partner with each patient to develop a custom
weight management program to best meet their individual needs taking into account their medical history, lifestyle and goals.
Since weight and sleep go together, most of the W8MD centers are able to address sleep issues such as snoring, obstructive sleep apnea, narcolepsy, insomnia and restless leg syndrome to name a few.
And the best part of the program is that most insurance’s cover the doctor visits.
Check out our website at http://www.w8md.com to learn more about us. If you have a little or a lot of weight to lose and want to do it without surgery, set up fees and mandatory meal replacements or appetite suppressants, think W8MD for weight loss.
And, if you are a physician, with an interest in helping your obese or overweight patients, and would like to add a W8MD program at your office, please feel free to contact us.
Specialties: Weight Loss Service, Qsymia, Belviq, Topiramate, Phentermine, VLCD Diet, Low Calorie Diet, Sleep Clinic, Sleep Study Clinics, Sleep Apnea Clinic, Medical Weight Loss, Weight Loss Pills, Weight Loss Supplements, Fast Weight Loss Options, weight loss diet, weight loss program, Lose Weight Philadelphia, Weight Loss NYC, New York Weight Loss Clinic, Adipex, Phentermine, Generic Phentermine Topirmate, Weight Loss Diet Pills, NYC Weight Loss Service
Cities Served:Philadelphia, King Of Prussia, Wayne, Brooklyn, Staten Island, Manhattan, New York, New York City, Queens, Long Island, Bronx, Bensonhurst.